CPC
GSK icon

Cookson Peirce & Co’s GSK GSK Stock Holding History

Cookson Peirce & Co’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-15,174
Closed -$620K – 282
2024
Q3 		$620K Sell
15,174
-1,116
-7% -$45.7K 0.03% 153
2024
Q2 		$627K Buy
16,290
+287
+2% +$12.1K 0.03% 141
2024
Q1 		$686K Buy
+16,003
New +$660K 0.04% 132

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Cookson Peirce & Co's GSK Position: Q4 2024 in Review

Cookson Peirce & Co sold out of GSK (GSK) in Q4 2024, closing a stake of 15,174 shares — an estimated $620K sold.

Cookson Peirce & Co first reported a position in GSK in Q1 2024 and held it in 3 quarters. The position peaked at $686K in Q1 2024. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

  • Cookson Peirce & Co reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
  • Cookson Peirce & Co sold 15,174 GSK shares in Q4 2024, an estimated $620K.
  • Cookson Peirce & Co first reported a position in GSK in Q1 2024 and held it in 3 quarters.
  • Cookson Peirce & Co's GSK position peaked at $686K in Q1 2024.
  • 848 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Cookson Peirce & Co's 13F filing for Q4 2024, filed 6 Feb 2025.